<!--https://www.openaustralia.org.au/debates/?id=2023-02-08.45.1-->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
 <head>
  <meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
  <title>
   Pharmaceutical Benefits Scheme: 8 Feb 2023: House debates (OpenAustralia.org)
  </title>
  <meta content="Making parliament easy." name="description"/>
  <meta content="Parliament, government, House of Representatives, Senate, Senator, MP, Member of Parliament, MPs, Australia, Australian, Pharmaceutical Benefits Scheme: 8 Feb 2023" name="keywords"/>
  <meta content="5FBaCDi8kCKdo4s64NEdB5EOJDNc310SwcLLYHmEbgg=" name="verify-v1"/>
  <meta content="width=device-width; initial-scale=1.0; maximum-scale=1.0" name="viewport">
   <link href="mailto:contact@openaustralia.org" rel="author" title="Send feedback"/>
   <link href="http://www.openaustralia.org.au/" rel="home" title="Home"/>
   <link href="/" rel="start" title="Home"/>
   <!-- skin: mobile -->
   <link href="/style/default/global_non_ns4_mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/print.css" media="print" rel="stylesheet" type="text/css"/>
   <script type="text/javascript">
    var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
   </script>
   <script type="text/javascript">
    var pageTracker = _gat._getTracker("UA-3107958-3");
pageTracker._initData();
pageTracker._trackPageview();
   </script>
  </meta>
 </head>
 <body>
  <div id="container">
   <a name="top">
   </a>
   <div id="banner">
    <div id="title">
     <h1>
      <a href="/" title="To the front page of the site">
       <img alt="OpenAustralia.org beta" height="32" src="/images/openaustraliaorgbeta.gif" width="262"/>
      </a>
     </h1>
    </div>
   </div>
   <!-- end #banner -->
   <div id="content">
    <div class="stripe-head-1">
     <div class="main">
      <h2>
       House debates
      </h2>
      <h3>
       Wednesday, 8 February 2023
      </h3>
      <h4>
       Statements by Members
      </h4>
      <h5>
       Pharmaceutical Benefits Scheme
      </h5>
      <p>
       1:47 pm
      </p>
      <a name="g45.2">
      </a>
      <p class="speaker">
       <a href="/mp/?m=641" title="See more information about Michelle Landry">
        <img alt="Photo of Michelle Landry" class="portrait" src="/images/mps/10789.jpg"/>
        <strong>
         Michelle Landry
        </strong>
       </a>
       <small>
        (Capricornia, National Party, Shadow Assistant Minister for Manufacturing) |
        <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;adv=yes;orderBy=_fragment_number,doc_date-rev;page=0;query=Dataset%3Ahansardr,hansardr80%20Date%3A8%2F2%2F2023;rec=0;resCount=Default" title="The source of this piece of text">
         Hansard source
        </a>
        <!-- | <script type="text/javascript" src="http://parlvid.mysociety.org/video.cgi?gid=2023-02-08.45.2&output=js-link"></script> -->
       </small>
       <p>
        I recently met with little Mila, who has cystic fibrosis, and her parents, Jaimee and Mitchell, to discuss the urgent need for Trikafta to be added to the
        <a href="http://en.wikipedia.org/wiki/Pharmaceutical_Benefits_Scheme" rel="nofollow">
         Pharmaceutical Benefits Scheme
        </a>
        . Every day, Mila battles this devastating illness through multiple medications and physiotherapy treatments. Yet there is hope for Mila and many other children like her who suffer daily. Trikafta is a miracle drug that can prevent further deterioration of the lungs and airways, limiting the damage on the body. Last year, the coalition government recognised the critical need to add Trikafta to the PBS and made it available for those aged 12 and over. The
        <a href="http://en.wikipedia.org/wiki/Pharmaceutical_Benefits_Advisory_Committee" rel="nofollow">
         Pharmaceutical Benefits Advisory Committee
        </a>
        approved Trikafta for use for children between the ages of six and 11 before Christmas last year. Unfortunately, this has not turned out to be the Christmas present families were hoping for. Two months have gone by, and the bureaucratic red tape is delaying access to this treatment, with costs of over $250,000 a year to access Trikafta. This leaves the medication out of reach for most children.
       </p>
       <p>
        Once this medication is on the PBS, 90 per cent of those suffering from cystic fibrosis can be treated. These children don't have the luxury of time on their side. The sooner it is placed on the PBS, the sooner the life-altering conditions associated with cystic fibrosis can be halted. This needs to be done urgently so children like Mila can look forward to a long and healthy life.
       </p>
       <br/>
       <br/>
       <br/>
       <br/>
       <div id="footer">
        <p>
         <a href="/?show_pc">
          View the PC OA website
         </a>
        </p>
       </div>
      </p>
     </div>
    </div>
   </div>
  </div>
 </body>
</html>
